Apollo Cancer Centres Introduces End-O Check

News Desk, News Nation 360 : Apollo Cancer Centres (ACCs) introduced End-O Check, a comprehensive early detection program aimed at women 45 years of age and older, further solidifying its dedication to preventative oncology for women. The goal of the program is to identify endometrial and ovarian cancers, two of the most common gynaecologic tumours, early on so they may be treated. End-O Check empowers women to take charge of their gynaecologic health by emphasising early identification in high-risk populations, symptom awareness, and prompt action. Dr Subrato R Debnath, Senior Consultant – Gynae Oncology and Robotic Surgeon, Apollo Cancer Centre, Kolkata, stated that early detection is essential for better results because endometrial cancer has been increasing in women over 45. According to global data, the five-year survival rate for localised disease is approximately 96%. However, delayed diagnosis significantly lowers survival rates, highlighting the significance of early identification. Obesity, diabetes, early menstruation, late menopause, and polycystic ovarian syndrome (PCOS) are important risk factors that are more common in Indian women. Ovarian cancer, or the "silent killer," typically strikes women between 55 and 64 years of age, with the mean diagnosis age at 63, and where it is diagnosed early, the five-year survival rate is over 90%, but early detection is still elusive as the disease presents with mild or no symptoms. In India, it is projected that cancer incidence will increase to 1.57 million by 2025, and ovarian and uterine cancers are among the top five cancers affecting women, with age-standardised incidence rates of 4.6 per 100,000 for ovarian and 2.5 per 100,000 for uterine (corpus) cancers. These trends are driven by shifts in reproductive behaviour, growing urbanisation, and more prevalent metabolic disorders, all of which indicate the need for targeted detection and screening of more at-risk women. In contrast to ovarian cancer, endometrial (uterine) cancer tends to produce symptoms like abnormal discharge or bleeding, but most women do not report these early warning signs in time, leading to delayed diagnoses and increased risk of adverse outcomes. This situation emphasises increased awareness, early reporting of signs, and enhanced early detection and prevention measures to curb cancer mortality rates among women.

Pic - Courtesy